Revenues Sales commission and other 79 131 169 284 Licensing revenue 89 112 24,657 220 Total revenues 168 243 24,826 504 Cost of goods sold 197 — 197 — Research and development costs 974 3,599 1,807 6,054 General and administrative expenses 2,004 1,874 4,790 3,755 Selling expenses 497 1,449 2,138 2,991 Total operating expenses 3,475 6,922 8,735 12,800 (Loss) income from operations (3,504 ) (6,679 ) 15,894 (12,296 ) Gain due to changes in foreign currency exchange rates 677 196 725 261 Change in fair value of warrant liability (134 ) 3,914 1,694 5,317 Other finance income 126 19 144 37 Net finance income 669 4,129 2,563 5,615 (Loss) income before income taxes (2,835 ) (2,550 ) 18,457 (6,681 ) Income taxes 233 — (6,635 ) — Net (loss) income (2,602 ) (2,550 ) 11,822 (6,681 ) Other comprehensive income (loss): Items that may be reclassified subsequently to profit or loss: Foreign currency translation adjustments (28 ) (659 ) (250 ) (792 ) Items that will not be reclassified to profit or loss: Actuarial gain on defined benefit plans 205 194 205 635 Comprehensive (loss) income (2,425 ) (3,015 ) 11,777 (6,838 ) Net (loss) income per share (basic) (0.16 ) (0.18 ) 0.72 (0.49 ) Net (loss) income per share (diluted) (0.16 ) (0.18 ) 0.70 (0.49 ) Weighted average number of shares outstanding:
Basic§ 16,440,760 14,086,508 16,440,760 13,776,045
Diluted§ 16,440,760 14,086,508 16,489,364 13,776,045
Condensed Interim Consolidated Statement of Financial Position Information (in thousands, except share and per share data) As at June 30, As at December 31, 2018 2017 $ $ Cash and cash equivalents 19,946 7,780 Trade and other receivables and other current assets 1,367 958
Inventory§ 1,397 643 Restricted cash equivalents 373 381 Property, plant and equipment 75 101 Deferred tax assets — 3,479 Other non-current assets 8,476 8,853 Total assets 31,634 22,195 Payables and other current liabilities 2,146 2,987 Current portion of deferred revenues — 486 Warrant liability 2,203 3,897 Provision for restructuring costs 566 2,296 Taxes payable 2,904 — Non-financial non-current liabilities 14,305 15,312 Total liabilities 22,124 24,978 Shareholders' equity (deficiency) 9,510 (2,783) Total liabilities and shareholders' equity (deficiency) 31,634 22,195
|